Home LiteratureArticle Details
PMID: 12559867 Published · ppublish English Journal Article

Incidence of retinoblastoma in children born after in-vitro fertilisation.

Lancet (London, England) ·Vol. 361 ·No. 9354 ·2003-01-25 ·Pages 309-10

Moll AC, Imhof SM, Cruysberg JR, Schouten-van Meeteren AY, Boers M, van Leeuwen FE

Abstract

Every year, 3000 women in the Netherlands are treated with in-vitro fertilisation (IVF), and results from studies suggest that the offspring of these women do not have a heightened risk of cancer. Between November, 2000, and February, 2002, we diagnosed retinoblastoma in five patients born after IVF. To calculate the relative risk of the disease, we assumed that the proportion of children conceived by IVF in the Netherlands is between 1.0 and 1.5%, and that the five patients who we diagnosed with the disease represent all new cases in the Netherlands during that period. Relative risks for retinoblastoma were significantly raised (7.2 [95% CI 2.4-17.0], and 4.9 [1.6-11.3], for 1% and 1.5% rates, respectively). This possible association of an increased risk of retinoblastoma in a population-based study needs to be established.

MeSH Terms
Child, Preschool Female Fertilization in Vitro/adverse effects Humans Incidence Infant Male Netherlands/epidemiology Retinal Neoplasms/epidemiology,etiology Retinoblastoma/epidemiology,etiology
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Moll Annette C
Department of Ophthalmology, Vrije Universiteit Medical Centre, 1081 HV, Amsterdam, Netherlands. [email protected]
Imhof Saskia M
Cruysberg Johannes R M
Schouten-van Meeteren Antoinette Y N
Boers Maarten
van Leeuwen Flora E
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
2003-01-25
Pages
309-10
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]